High PSA: causes, levels and what your results mean

High PSA (prostate-specific antigen): what counts as raised at your age, the everyday reasons it climbs, your real chance of cancer at each level, and the usual next steps.

Reviewed by LifeFrom’s medical AIPublished November 17, 2026 · 9
Ask AI about this pageChatGPTClaudePerplexity
The distinctions
  1. 01
    A raised PSA is a leak signal

    PSA rises whenever the prostate leaks more of it into the blood, from enlargement, inflammation, a recent trigger or cancer. The number says something is happening in the prostate; the repeat test, free PSA, MRI and biopsy say what.

  2. 02
    The cut-off is a sliding scale

    Cancer was found in 6.6% of men with PSA under 0.5 ng/mL and 26.9% at 3.1 to 4.0 ng/mL in the Prostate Cancer Prevention Trial, so 4.0 ng/mL is one point on a rising slope of risk.

PSA (prostate-specific antigen) is a protein made by the prostate gland, and a small amount always leaks into the blood. A high result means more is leaking than expected for your age: it tells you something is going on in the prostate, but it cannot say what. Enlargement, inflammation, a recent ride or ejaculation and cancer can all push the number up, so the first job is to rule out the temporary causes and repeat the test under clean conditions. For what the test measures and the full normal ranges, see the main total PSA (tPSA) page; this page covers what a raised number means and what usually comes next.

What counts as high

Most US labs flag total PSA above 4.0 ng/mL. The units ng/mL and µg/L give the same number, so 4.0 ng/mL is 4.0 µg/L on a UK or European report (how lab units work). The 4.0 line is blunt. PSA rises with age as the prostate grows, so a PSA of 3.8 ng/mL means something different at 45 than at 75.

Where an example PSA of 5.2 ng/mL sitsng/mL

5.2 ng/mLAbove the usual cut-off · same as 5.2 µg/L
Below 2.50–2.52.5 to 4.0: flagged for younger men2.5–44 to 104–10Above 1010–12
A PSA of 5.2 ng/mL is above the classic 4.0 limit, and above the age-specific limit for men under 70. The usual next step is a repeat test after a clean 48 hours, then a talk with your clinician about whether further tests would change the plan.
Cut-offs: 4.0 ng/mL classic limit; age-specific limits of 2.5 (40s) and 3.5 (50s) ng/mL from Oesterling 1993 3; about 1 in 4 biopsies for a raised PSA find cancer 1.

In 1993, Oesterling and colleagues measured PSA in a community sample of healthy men in Olmsted County, Minnesota, and set an upper limit for each decade of age 3. Many labs and reading tools still use these limits.

AgeAge-specific upper limit (ng/mL)Same limit in µg/LAbove this reads as
40 to 492.52.5High for age
50 to 593.53.5High for age
60 to 694.54.5High for age
70 to 796.56.5High for age

The Oesterling limits came from a mostly white group of men, so they may sit too high for men at higher risk. The AUA/SUO guideline (from the American Urological Association and the Society of Urologic Oncology) treats Black ancestry, inherited mutations such as BRCA2 and a strong family history as higher risk, and suggests a first PSA at 40 to 45 for those men instead of 45 to 50 2. No guideline grades PSA in multiples of the upper limit the way liver enzymes are graded. The useful scale for PSA is the chance of finding cancer at each level.

How likely is cancer at your number

The Prostate Cancer Prevention Trial biopsied men whose PSA had stayed at or below 4.0 ng/mL for seven years, so it shows what sits under the line most people treat as safe 4. Cancer turned up at every level, and the share rose steadily with PSA.

PSA (ng/mL)Chance of cancer on biopsySource
0 to 0.56.6%Prostate Cancer Prevention Trial 4
0.6 to 1.010.1%Prostate Cancer Prevention Trial 4
1.1 to 2.017.0%Prostate Cancer Prevention Trial 4
2.1 to 3.023.9%Prostate Cancer Prevention Trial 4
3.1 to 4.026.9%Prostate Cancer Prevention Trial 4
Above 4.0, biopsied for a raised PSAAbout 25%National Cancer Institute 1

When it is urgent

When to get help now

PSA has no lab critical value. Urgency comes from symptoms, and any PSA level with one of these changes the timeline.

Call 911 or your local emergency number
  • You cannot pass urine, or only a dribble, with a swollen, painful lower belly: emergency care now.
  • Fever, chills or shaking with painful or burning urination: same-day care, since an acute prostate infection can make you very unwell and pushes PSA far above the limit.
  • Severe pain in the pelvis, between the legs or in the back passage with a fever: same-day care.
See a doctor soon, the same day if you can
  • Blood in your urine or semen: see a clinician within days.
  • New bone or back pain, or weight loss you cannot explain, alongside a raised PSA: book a prompt appointment and mention the PSA result.
  • A PSA that has climbed while on testosterone therapy: tell the prescriber before the next review is due.

LifeFrom can't examine you or assess a symptom. If something feels seriously wrong, trust that and get care rather than waiting on a test.

Is it really high?

A single raised PSA often has an everyday explanation. The National Cancer Institute names ejaculation, vigorous exercise such as cycling, prostate infection or inflammation, a recent prostate biopsy and drugs such as finasteride among the things that move PSA 1. Check each one against the day of your draw before reading anything into the number.

What happenedEffect on PSAHow long it lastsBefore the retest
Ejaculation in the 2 days before the drawSmall riseAbout 2 daysAvoid ejaculation for 2 days 1
Long cycling or other vigorous exerciseSmall riseAbout 2 daysRest for 2 days (exercise before a blood test) 1
Prostate infection or prostatitis (inflammation of the prostate)Can be largeA month or two 1Retest once it has cleared, at a time your clinician sets 1
Prostate biopsyCan be largeA month or two 1Ask the team that did the procedure how long to wait; the same goes for a catheter or cystoscopy (a camera into the bladder)
Finasteride or dutasterideLowers PSA by about half in the first 12 monthsAs long as you take itClinicians adjust the measured value upward, roughly doubling it 8
Testosterone therapyModest rise, mostly in the first monthsWhile on therapySee the testosterone section below 7
A different labAssays read slightly differentlyEvery testRetest at the same lab

Finasteride and dutasteride (5-alpha reductase inhibitors, prescribed for an enlarged prostate or hair loss) block the conversion of testosterone to DHT, and the prostate shrinks and makes less PSA. Finasteride cuts PSA by about 50% in the first 12 months, and in the Prostate Cancer Prevention Trial the factor needed to correct for it rose from 2 at two years to 2.5 at seven years 8. A PSA of 2.5 ng/mL after two years on finasteride therefore reads roughly like 5.0 ng/mL.

For people with a newly elevated PSA, clinicians should repeat the PSA prior to a secondary biomarker, imaging, or biopsy.AUA/SUO Early Detection of Prostate Cancer guideline, 2023 2

The repeat earns its place. In 972 men who gave a blood sample once a year for four years, 44% of those with a PSA above 4 ng/mL had a normal value on at least one later test 5. The authors concluded that a single raised PSA should be confirmed several weeks later before biopsy. The National Cancer Institute notes that a doctor may repeat an abnormal screening PSA in about 6 to 8 weeks in a man with no symptoms 1.

Causes

What raises PSA, most likely first

Each cause has a clue that points to it and a test that confirms it. Prostate cancer comes last because it is the least common explanation for a single raised PSA; it still has to be ruled out.

  1. 01
    Enlarged prostate (BPH)Medicalcommon

    BPH (benign prostatic hyperplasia) is non-cancer growth of the gland; a bigger prostate releases more PSA 1. Clue: a weak stream, getting up at night to urinate, a large gland on exam. Confirmed by exam and imaging, with free PSA as a pointer.

    Free/total PSA ratio
    A higher free share leans toward BPH
  2. 02
    Prostatitis or urinary infectionMedicalcommon

    Inflammation or infection of the prostate lets more PSA leak into the blood, for a month or two 1. Clue: burning, fever, pelvic or perineal pain. Confirmed by urine tests; fever with painful urination needs same-day care.

    White cells in urine
    Raised in infection
  3. 03
    A recent triggerEverydaycommon

    Ejaculation or vigorous exercise in the 2 days before the draw, or a recent prostate biopsy, lifts PSA for a while 1. Clue: the timing of the draw. Confirmed by a clean repeat PSA.

    Total PSA
    Back in range on repeat
  4. 04
    Testosterone therapyMedicalless common

    Restoring testosterone in men with low levels raises PSA modestly, mostly in the first months 7. Clue: the rise follows the start of treatment. Confirmed by the testosterone level and a repeat PSA against the Endocrine Society thresholds.

    Total testosterone
    Shows the dose effect
  5. 05
    Prostate cancer (must not miss)Medicalless common

    Cancer disrupts the gland's structure so more PSA reaches the blood; about 1 in 4 men biopsied for a raised PSA have it 1. Clue: a PSA that stays raised on repeat, a low free share, a hard area on exam. Confirmed by MRI and biopsy. Early cancer is usually silent; new bone pain or weight loss with a high PSA needs a prompt appointment.

    Free PSA
    A lower free share leans toward cancer

These are things a symptom like this can be linked with, not a diagnosis. Several can sit together, and a clinician who knows your history puts them in order for you.

Symptoms

PSA causes no symptoms at any level. Any symptoms come from whatever is raising it. Urinary symptoms such as a weak stream, urgency or getting up at night (see frequent urination) point toward an enlarged prostate, but they do not rule cancer in or out, because early prostate cancer usually causes no symptoms, which is why screening is aimed at men without them 1. Fever, burning and pelvic pain point toward infection. A raised PSA does not cause tiredness or erection problems, so if those are present they need their own explanation.

Read it with your other markers

PatternWhat it suggestsRead more
Total PSA 4 to 10, free PSA above 25%Leans toward an enlarged prostate 9Free/total PSA ratio
Total PSA 4 to 10, free PSA 25% or lowerHigher chance of cancer; more work-up likely 9Free PSA
Raised PSA plus white cells in urineInfection or prostatitisHigh white cells in urine
PSA up after starting testosteroneTherapy effect, checked against Endocrine Society thresholds 7TRT blood work
PSA lower than expected on finasterideMasked value; roughly doubled to read it 8DHT

High PSA on testosterone therapy

The Endocrine Society guideline asks for a baseline PSA before testosterone therapy starts and a check 3 to 12 months in. It advises a urology review if PSA rises by more than 1.4 ng/mL within 12 months, if a confirmed PSA is above 4.0 ng/mL, or if the prostate exam is abnormal 7. A smaller rise is usually read as a therapy effect, judged against your own starting value. Any change to the dose or stopping is a decision for the prescriber; see TRT blood work for the full monitoring schedule.

What usually happens next

From a high PSA to an answer

1
Check the draw
Your clinician asks about ejaculation, cycling, infection, procedures and medicines in the days before the test 1.
2
Repeat the PSA
Usually after about 6 to 8 weeks with no symptoms, under clean conditions 1. Many raised values come back normal 5.
3
Add a test that changes the decision
If PSA stays up: free PSA percentage 9, a combined score such as PHI (Prostate Health Index) or 4Kscore, or PSA density (PSA divided by prostate volume) 2.
4
MRI before biopsy
An MRI scan picks out areas worth sampling. In the PRECISION trial, MRI with targeted biopsy found clinically significant cancer in 38% of men against 26% with standard biopsy 6.
5
Biopsy if the scan or scores point to it
Needle samples of the prostate, taken through the skin behind the scrotum or through the rectum, give the only firm diagnosis 1.
General sequence from the AUA/SUO guideline 2 and NCI 1; your urologist decides which steps apply.
28%of men in the MRI arm of PRECISION avoided a biopsyTheir scan did not look suspicious, so no needle sampling was done 6.
TestWhat it addsWhat it cannot tell you
Repeat total PSAShows whether the first rise was temporary 5Why PSA is raised
Free PSA percentageIn the 4 to 10 range, a 25% cut-off caught 95% of cancers and spared 20% of needless biopsies 9Whether a cancer is aggressive
PHI or 4KscoreA combined blood score for the chance of significant cancer 2Where in the gland a cancer sits
PSA densitySeparates a big benign gland from a small gland making too much PSAAnything without a measured prostate volume
MRIFinds and grades suspicious areas; can avoid a biopsy 6A firm diagnosis on its own
BiopsyThe diagnosis and the gradeCancer outside the sampled areas

A PSA that creeps up

PSA velocity is how fast PSA rises per year, and doubling time is how long it takes to double. Both can mislead, because PSA moves between draws in healthy men: the Eastham study measured this year-to-year fluctuation directly 5. The AUA/SUO guideline says velocity should not be the sole reason for further biomarkers, imaging or biopsy 2. A steady rise across three or more tests from the same lab, under the same prep, tells a clinician far more than two numbers a year apart; why trends beat single readings explains the logic.

What can bring it down

The goal of a follow-up is to find the cause, because a lower number on its own changes nothing about risk. These are the changes with real human evidence on PSA.

ChangeEffect on PSA in humansEvidenceSource
2 days without ejaculation or vigorous exercise before the drawRemoves a temporary riseGuideline adviceNCI 1
Treating a confirmed infection or prostatitisPSA falls back as the inflammation settlesGuideline adviceNCI 1
Finasteride or dutasteride, prescribed for BPH or hair lossAbout 50% lower in the first 12 months; cancer risk is not removed, so the value is adjusted upward to read itRCTEtzioni 2005 8

Supplements sold for prostate health, such as saw palmetto, and diet changes have no trial evidence of lowering PSA in a way that changes cancer risk. How supplements affect blood tests covers the ones that do shift lab values.

Free, no accountRead your blood testHave the full report, or PSA results from two different dates? Read every marker on it free, and see whether a move is wobble or a clear rise.Read my results

Who gets tested and when

The AUA/SUO guideline suggests offering a baseline PSA at 45 to 50, and at 40 to 45 for men with Black ancestry, an inherited mutation such as BRCA2 or a strong family history 2. Screening finds cancers that would never have caused harm as well as ones that would, so the decision to test is a shared one with your clinician. For where PSA fits among other cancer blood tests, see tumor markers explained and blood tests for men.

Free, no accountDrop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.
Citations
  1. National Cancer Institute. Prostate-Specific Antigen (PSA) Test fact sheet.
  2. Wei JT et al. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. J Urol 2023;210:46-53.
  3. Oesterling JE et al. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 1993;270:860-4.
  4. Thompson IM et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 2004;350:2239-46.
  5. Eastham JA et al. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA 2003;289:2695-2700.
  6. Kasivisvanathan V et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis (PRECISION). N Engl J Med 2018;378:1767-77.
  7. Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103:1715-44.
  8. Etzioni RD et al. Long-term effects of finasteride on prostate specific antigen levels: results from the Prostate Cancer Prevention Trial. J Urol 2005;174:877-81.
  9. Catalona WJ et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998;279:1542-7.

Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.